Challenges and strategies for ocular posterior diseases therapy via non-invasive advanced drug delivery

被引:22
|
作者
Qi, Qi [1 ]
Wei, Yidan [1 ]
Zhang, Xin [1 ]
Guan, Jian [1 ]
Mao, Shirui [1 ]
机构
[1] Shenyang Pharmaceut Univ, Sch Pharm, 103 Wenhua Rd, Shenyang 110016, Peoples R China
关键词
Ocular posterior segment; Non-invasive; Topical drug delivery; Nanocarriers; NANOSTRUCTURED LIPID CARRIERS; RETINAL-PIGMENT EPITHELIUM; CONTACT-LENSES; TRIAMCINOLONE ACETONIDE; PHYSIOLOGICAL BARRIERS; POLYMERIC MICELLES; TEAR FILM; NANOPARTICLES; EYE; SEGMENT;
D O I
10.1016/j.jconrel.2023.07.055
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Posterior segment diseases, such as age-related macular degeneration (AMD) and diabetic retinopathy (DR) are vital factor that seriously threatens human vision health and quality of life, the treatment of which poses a great challenge to ophthalmologists and ophthalmic scientists. In particular, ocular posterior drug delivery in a noninvasive manner is highly desired but still faces many difficulties such as rapid drug clearance, limited permeability and low drug accumulation at the target site. At present, many novel non-invasive topical ocular drug delivery systems are under development aiming to improve drug delivery efficiency and biocompatibility for better therapy of posterior segment oculopathy. The purpose of this review is to present the challenges in the noninvasive treatment of posterior segment diseases, and to propose strategies to tackle these bottlenecks. First of all, barriers to ocular administration were introduced based on ocular physiological structure and behavior, including analysis and discussion on the influence of ocular structures on noninvasive posterior segment delivery. Thereafter, various routes of posterior drug delivery, both invasive and noninvasive, were illustrated, along with the respective anatomical obstacles that need to be overcome. The widespread and risky application of invasive drug delivery, and the need to develop non-invasive local drug delivery with alternative to injectable therapy were described. Absorption routes through topical administration and strategies to enhance ocular posterior drug delivery were then discussed. As a follow-up, an up-to-date research advances in non-invasive delivery systems for the therapy of ocular fundus lesions were presented, including different nanocarriers, contact lenses, and several other carriers. In conclusion, it seems feasible and promising to treat posterior oculopathy via non-invasive local preparations or in combination with appropriate devices.
引用
收藏
页码:191 / 211
页数:21
相关论文
共 50 条
  • [41] Strategies for Drug Delivery into the Brain: A Review on Adenosine Receptors Modulation for Central Nervous System Diseases Therapy
    Fernandez, Mercedes
    Nigro, Manuela
    Travagli, Alessia
    Pasquini, Silvia
    Vincenzi, Fabrizio
    Varani, Katia
    Borea, Pier Andrea
    Merighi, Stefania
    Gessi, Stefania
    PHARMACEUTICS, 2023, 15 (10)
  • [42] Mucoadhesive drug delivery systems: a promising non-invasive approach to bioavailability enhancement. Part I: biophysical considerations
    Kulkarni, Radha
    Fanse, Suraj
    Burgess, Diane J.
    EXPERT OPINION ON DRUG DELIVERY, 2023, 20 (03) : 395 - 412
  • [43] Drug delivery to the ocular posterior segment using lipid emulsion via eye drop administration: Effect of emulsion formulations and surface modification
    Ying, Lin
    Tahara, Kohei
    Takeuchi, Hirofumi
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2013, 453 (02) : 329 - 335
  • [44] Chitosan/bovine serum albumin layer-by-layer assembled particles for non-invasive inhaled drug delivery to the lungs
    Chauhan, Gautam
    Wang, Xuechun
    Quadros, Mural
    Vats, Mukti
    Gupta, Vivek
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 271
  • [45] Non-invasive topical drug delivery to spinal cord with carboxyl-modified trifunctional copolymer of ethylene oxide and propylene oxide
    Kamalov, Marat I.
    Lavrov, Igor A.
    Yergeshov, Abdulla A.
    Siraeva, Zulfira Y.
    Baltin, Maxim E.
    Rizvanov, Albert A.
    Kuznetcova, Svetlana V.
    Petrova, Natalia V.
    Savina, Irina N.
    Abdullin, Timur I.
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2016, 140 : 196 - 203
  • [46] Non-invasive evaluation of transdermal drug delivery using 3-D transient triplet differential (TTD) photoacoustic imaging
    Xie, Yang
    Wu, Huayi
    Chen, Ziyan
    Sun, Qi
    Liu, Xiangdong
    Jiang, Jinsheng
    Wang, Bo
    Chen, Zeyu
    PHOTOACOUSTICS, 2023, 32
  • [47] Evaluation of the feasibility and use of a prototype remote drug delivery capsule (RDDC) for non-invasive regional drug absorption studies in the GI tract of man and beagle dog
    Parr, AF
    Sandefer, EP
    Wissel, P
    McCartney, M
    McClain, C
    Ryo, UY
    Digenis, GA
    PHARMACEUTICAL RESEARCH, 1999, 16 (02) : 266 - 271
  • [48] Evaluation of the Feasibility and Use of a Prototype Remote Drug Delivery Capsule (RDDC) for Non-Invasive Regional Drug Absorption Studies in the GI Tract of Man and Beagle Dog
    Alan F. Parr
    Erik P. Sandefer
    Paul Wissel
    Mike McCartney
    Craig McClain
    U. Y. Ryo
    George A. Digenis
    Pharmaceutical Research, 1999, 16 : 266 - 271
  • [49] Nose-to-brain delivery of hyaluronate - FG loop peptide conjugate for non-invasive hypoxic-ischemic encephalopathy therapy
    Kim, Yun Seop
    Sung, Dong Kyung
    Kim, Hyemin
    Kong, Won Ho
    Kim, Young Eun
    Hahn, Sei Kwang
    JOURNAL OF CONTROLLED RELEASE, 2019, 307 : 76 - 89
  • [50] Preclinical development and ocular biodistribution of gemini-DNA nanoparticles after intravitreal and topical administration: Towards non-invasive glaucoma gene therapy
    Alqawlaq, Samih
    Sivak, Jeremy M.
    Huzil, J. Torin
    Ivanova, Marina V.
    Flanagan, John G.
    Beazely, Michael A.
    Foldvari, Marianna
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2014, 10 (08) : 1637 - 1647